Next Century Growth Investors’s TELA Bio TELA Stock Holding History

Next Century Growth Investors’s Portfolio TELA Stock Details TELA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-473,131	Closed	-$3.79M	–	128
2023 Q3	$3.79M	Sell	473,131 -301,781	-39%	-$2.8M	0.41%	66
2023 Q2	$7.85M	Sell	774,912 -2,841	-0.4%	-$29.1K	0.76%	43
2023 Q1	$8.28M	Buy	777,753 +2,695	+0.3%	+$29.7K	0.91%	41
2022 Q4	$8.91M	Buy	775,058 +73,640	+10%	+$660K	1.07%	36
2022 Q3	$5.98M	Buy	+701,418	New	+$5.82M	0.73%	43

Other funds holding TELA

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Next Century Growth Investors's TELA Position: Q4 2023 in Review

Next Century Growth Investors sold out of TELA Bio (TELA) in Q4 2023, closing a stake of 473,131 shares — an estimated $3.79M sold.

Next Century Growth Investors first reported a position in TELA in Q3 2022 and held it in 5 quarters. The position peaked at $8.91M in Q4 2022. 60 funds tracked by Wall St. Rank hold TELA as of Q4 2023.

Next Century Growth Investors reported no remaining TELA Bio position as of Q4 2023 after selling out during the quarter.
Next Century Growth Investors sold 473,131 TELA Bio shares in Q4 2023, an estimated $3.79M.
Next Century Growth Investors first reported a position in TELA Bio in Q3 2022 and held it in 5 quarters.
Next Century Growth Investors's TELA Bio position peaked at $8.91M in Q4 2022.
60 funds tracked by Wall St. Rank held TELA Bio as of Q4 2023.

Based on Next Century Growth Investors's 13F filing for Q4 2023, filed 14 Feb 2024.